{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,8,6]],"date-time":"2024-08-06T08:06:13Z","timestamp":1722931573715},"reference-count":28,"publisher":"Wiley","issue":"2","license":[{"start":{"date-parts":[[2009,12,14]],"date-time":"2009-12-14T00:00:00Z","timestamp":1260748800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Deutsche Derma Gesell"],"published-print":{"date-parts":[[2010,2]]},"abstract":"<jats:title>Summary<\/jats:title><jats:p> <jats:italic>Background:<\/jats:italic> After the introduction of antiretroviral therapy, the life expectancy of HIV patients has increased to more than 30 years after initial diagnosis. Cardiovascular disease now is an important cause of death in HIV\u2010infected patients.<\/jats:p><jats:p> <jats:italic>Patients and Methods:<\/jats:italic> In the multicenter, prospective HIV\u2010HEART study, 222 (38 %) patients suffered from lipodystrophy. Women were more often affected than men (41.5 % vs. 25.3 %). Patients with lipodystrophy were on average 5 years older and had been infected longer (10.4 vs. 6.6 years) then patients without lipodystrophy. <jats:italic>Results:<\/jats:italic> Lipodystrophy in HIV patients was a clinical sign of cardiovascular risk factors like hyperlipidemia (total cholesterol 19 mg\/dl higher, HDL 2.8 mg\/dl lower, triglycerides 53 mg\/dl higher) and type 2 diabetes (11.3 % vs. 2.8 %). Patients with lipodystrophy were more likely to be co\u2010infected with hepatitis B (34.7 % vs. 28.8 %, p = 0.122) or C (13.1 % vs. 9.3 %, p = 0.16) than patients without lipodystrophy. The quality of life was reduced in patients with lipodystrophy. In 6 of 8 scales of the SF\u201036 questionnaire, patients with lipodystrophy had lower scores.<\/jats:p><jats:p> <jats:italic>Conclusions:<\/jats:italic> Lipodystrophy syndrome is an early warning system for a number of illnesses which reduce life expectancy. Dermatologists must help insure that HIV\u2010infected patients receive treatment for these disorders.<\/jats:p>","DOI":"10.1111\/j.1610-0387.2009.07330.x","type":"journal-article","created":{"date-parts":[[2010,7,29]],"date-time":"2010-07-29T18:02:35Z","timestamp":1280426555000},"page":"92-97","source":"Crossref","is-referenced-by-count":2,"title":["Lipodystrophy \u2013 a sign for metabolic syndrome in patients of the HIV\u2010HEART study"],"prefix":"10.1111","volume":"8","author":[{"given":"Anja","family":"Potthoff","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Norbert H.","family":"Brockmeyer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G\u00f6tz","family":"Gelbrich","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kathrin","family":"Neuhaus","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stefan","family":"Esser","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nico","family":"Reinsch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martin","family":"Hower","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarah","family":"Mostardt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anja","family":"Neumann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Till","family":"Neumann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"name":"For the Competence Center Cardiac Insufficiency and the Competence Network HIV\/AIDS","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2010,1,25]]},"reference":[{"doi-asserted-by":"publisher","key":"e_1_2_7_2_2","DOI":"10.1016\/S0140-6736(03)13802-0"},{"key":"e_1_2_7_3_2","first-page":"1","article-title":"HIV\u2010associated lipodystrophy \u2013 review of current therapy options","volume":"13","author":"Bechara FG","year":"2008","journal-title":"Eur J Med Res"},{"doi-asserted-by":"publisher","key":"e_1_2_7_4_2","DOI":"10.1146\/annurev.med.55.091902.104412"},{"doi-asserted-by":"publisher","key":"e_1_2_7_5_2","DOI":"10.1136\/hrt.2008.161463"},{"doi-asserted-by":"publisher","key":"e_1_2_7_6_2","DOI":"10.1097\/00002030-200404300-00011"},{"doi-asserted-by":"publisher","key":"e_1_2_7_7_2","DOI":"10.1111\/j.1468-1293.2009.00697.x"},{"doi-asserted-by":"publisher","key":"e_1_2_7_8_2","DOI":"10.1001\/jama.285.19.2486"},{"unstructured":"European AIDS Clinical Society (EACS).Guidelines on the Prevention and Management of Metabolic diseases in HIV. English version 4 October 2008http:\/\/www.europeanaidsclinicalsociety.org\/guidelinespdf\/2_Prevention_and_Management_of_Metabolic_diseases_in_HIV.pdf","key":"e_1_2_7_9_2"},{"doi-asserted-by":"publisher","key":"e_1_2_7_10_2","DOI":"10.1016\/S0140-6736(04)15489-5"},{"key":"e_1_2_7_11_2","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1177\/135965350300800303","article-title":"Rosiglitazone in the treatment of HAART\u2010associated lipodystrophy \u2013 a randomized double\u2010blind placebo\u2010controlled study","volume":"8","author":"Sutinen J","year":"2003","journal-title":"Antivir Ther"},{"doi-asserted-by":"publisher","key":"e_1_2_7_12_2","DOI":"10.7326\/0003-4819-143-5-200509060-00009"},{"doi-asserted-by":"publisher","key":"e_1_2_7_13_2","DOI":"10.1001\/jama.284.4.472"},{"key":"e_1_2_7_14_2","first-page":"243","article-title":"HIV\u2010HEART Study Investigative Group. Prevalence and natural history of heart failure in outpatient HIV\u2010infected subjects: rationale and design of the HIV\u2010HEART study","volume":"12","author":"Neumann T","year":"2007","journal-title":"Eur J Med Res"},{"unstructured":"LampingDL.Messung der Lebensqualit\u00e4t bei HIV\u2010Infektionen: Validierung des SF\u201036 Short\u2010Form Health Survey. Int Conf AIDS 1993 Jun 6\u201311; 9: 780 (abstract no. PO\u2010C35\u20103377).","key":"e_1_2_7_15_2"},{"unstructured":"http:\/\/www.sf\u201036.org\/","key":"e_1_2_7_16_2"},{"key":"e_1_2_7_17_2","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1177\/135965350901400307","article-title":"Incidence of lipodystrophy and metaoblic disorders in patients starting non\u2010nucleoside reverse transcriptase inhibitors in Benin","volume":"14","author":"Zannou DM","year":"2009","journal-title":"Anti-vir Ther"},{"doi-asserted-by":"publisher","key":"e_1_2_7_18_2","DOI":"10.1128\/AAC.01064-08"},{"issue":"2","key":"e_1_2_7_19_2","doi-asserted-by":"crossref","first-page":"M109","DOI":"10.1177\/135965350501002S12","article-title":"The role of hepatitis C virus (HCV) in mitochondrial DNA damage in HIV\/HCV\u2010coinfected individuals","volume":"10","author":"De Mendoza C","year":"2005","journal-title":"Antivir Ther"},{"doi-asserted-by":"publisher","key":"e_1_2_7_20_2","DOI":"10.1016\/j.jaad.2008.03.022"},{"doi-asserted-by":"publisher","key":"e_1_2_7_21_2","DOI":"10.1097\/BOR.0b013e3283257b96"},{"doi-asserted-by":"publisher","key":"e_1_2_7_22_2","DOI":"10.1161\/01.HYP.0000107251.49515.c2"},{"doi-asserted-by":"publisher","key":"e_1_2_7_23_2","DOI":"10.1097\/QAI.0b013e31817efb54"},{"doi-asserted-by":"publisher","key":"e_1_2_7_24_2","DOI":"10.1161\/01.RES.0000259591.97107.6c"},{"doi-asserted-by":"publisher","key":"e_1_2_7_25_2","DOI":"10.1038\/oby.2008.500"},{"doi-asserted-by":"publisher","key":"e_1_2_7_26_2","DOI":"10.1042\/CS20070166"},{"doi-asserted-by":"publisher","key":"e_1_2_7_27_2","DOI":"10.1097\/QAI.0b013e31815b0792"},{"doi-asserted-by":"publisher","key":"e_1_2_7_28_2","DOI":"10.1186\/1742-6405-6-8"},{"doi-asserted-by":"publisher","key":"e_1_2_7_29_2","DOI":"10.1097\/00006527-200601000-00006"}],"container-title":["JDDG: Journal der Deutschen Dermatologischen Gesellschaft"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1610-0387.2009.07330.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1610-0387.2009.07330.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,15]],"date-time":"2023-10-15T14:18:34Z","timestamp":1697379514000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1610-0387.2009.07330.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,1,25]]},"references-count":28,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2010,2]]}},"alternative-id":["10.1111\/j.1610-0387.2009.07330.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1610-0387.2009.07330.x","archive":["Portico"],"relation":{},"ISSN":["1610-0379","1610-0387"],"issn-type":[{"type":"print","value":"1610-0379"},{"type":"electronic","value":"1610-0387"}],"subject":[],"published":{"date-parts":[[2010,1,25]]}}}